We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
MyHealthChecked Plc | AQSE:MHC.GB | Aquis Stock Exchange | Ordinary Share | GB00BN7K5L93 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.50 | -4.44% | 10.75 | 9.00 | 11.00 | 11.25 | 10.00 | 11.25 | 0.00 | 15:29:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMHC
RNS Number : 0367N
MyHealthChecked PLC
18 January 2023
MyHealthChecked PLC
("MyHealthChecked" or the "Company")
Appointment of Dowgate as Broker
MyHealthChecked (AIM: MHC), the consumer home-testing healthcare company, announces the appointment of Dowgate Capital Limited ("Dowgate") as its Broker with immediate effect. SPARK Advisory Partners Limited will continue to act as the Company's Nominated Adviser.
For further information contact:
MyHealthChecked PLC www.myhealthchecked.com Penny McCormick, Chief Executive Officer via Walbrook SPARK Advisory Partners Limited (NOMAD) Tel: +44 (0)20 3368 3550 Neil Baldwin Dowgate Capital Limited (Broker) Tel: +44 (0)20 3903 7715 David Poutney / Nicholas Chambers Walbrook PR Limited (Media & IR) Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com Paul McManus Mob: +44 (0)7980 541 893
About MyHealthChecked ( www.myhealthcheckedplc.com )
MyHealthChecked, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
APPUBUBROVUAAAR
(END) Dow Jones Newswires
January 18, 2023 02:00 ET (07:00 GMT)
1 Year MyHealthChecked Chart |
1 Month MyHealthChecked Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions